首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Multiple sclerosis journal-experimental translational and clinical

缩写:

ISSN:N/A

e-ISSN:2055-2173

IF/分区:2.0/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引623
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
L E Charvet,M T Shaw,L Haider et al. L E Charvet et al.
Background: Cognitive impairment represents a critical unmet treatment need in multiple sclerosis (MS). Cognitive remediation is promising but traditionally requires multiple clinic visits to access treatment. Computer-ba...
Caroline Papeix,Laetitia Gambotti,Rana Assouad et al. Caroline Papeix et al.
Background: Disabled multiple sclerosis (MS) patients often need intervention of multiple specialists, resulting in a complex organization of care. How this multidisciplinary care should be organized and structured has no...
Anne Wickström,Peter Sundström,Lucas Wickström et al. Anne Wickström et al.
Background: Multiple sclerosis (MS) often causes a reduced ability to work. Improved disease control as well as adjustment of working conditions may improve work ability in MS. ...
Kevin R Patel,Jie Luo,Enrique Alvarez et al. Kevin R Patel et al.
Cortical lesions occur early in multiple sclerosis (MS) and are thought to have clinical implications. Conventional MRI is insensitive to cortical pathology. Investigational imaging modalities show improved but incomplete cortical lesion de...
Cécile Donzé,Lucie Malapel,Arnaud Kwiatkowski et al. Cécile Donzé et al.
Background: In multiple sclerosis (MS), treatment discontinuation leads to a higher risk of relapse, poorer quality of life and greater economic impact. O...
Juan Ignacio Rojas,Liliana Patrucco,Maria Trojano et al. Juan Ignacio Rojas et al.
Limited data suggest that multiple sclerosis (MS) in Latin America (LA) could be less severe than in the rest of the world. The objective was to compare the course of MS between LA and other regions. ...
Lahar Mehta,Manjit McNeill,Jeremy Hobart et al. Lahar Mehta et al.
Background: The 12-question Multiple Sclerosis Walking Scale (MSWS-12v1) is a widely-used patient-reported outcome (PRO) measure of walking ability in multiple sclerosis (MS). ...
Gerry Zm Ma,Lauren L Giuffrida,Melissa M Gresle et al. Gerry Zm Ma et al.
Background: The TAM family of receptor tyrosine kinases (TYRO3, AXL and MERTK) play important roles in modulating innate immune responses and central demyelination. The TAM receptor ligand Protein S (PROS) has also been s...
J P Stellmann,K L Young,J Pöttgen et al. J P Stellmann et al.
Background: Impaired low-contrast visual acuity (LCVA) is common in multiple sclerosis (MS) and other neurological diseases. Its assessment is often limited to selected contrasts, for example, 2.5% or 1.25%. Computerized ...
Charlotte Björkenstam,Kristina Alexanderson,Michael Wiberg et al. Charlotte Björkenstam et al.
Background: The variability of progression of multiple sclerosis (MS) suggests that MS is a heterogeneous entity. Objective: The object...